54 related articles for article (PubMed ID: 3998469)
1. Self-association of the seventh component of human complement (C7): dimerization and polymerization.
Pressner KT; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jul; 135(1):452-8. PubMed ID: 3998469
[TBL] [Abstract][Full Text] [Related]
2. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
Preissner KT; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
Yamamoto KI
J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
[TBL] [Abstract][Full Text] [Related]
4. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
Tschopp J; Chonn A; Hertig S; French LE
J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization.
Yamamoto K; Migita S
J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323
[TBL] [Abstract][Full Text] [Related]
6. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
7. Structural similarities between C6 and C7 of human complement.
Podack ER; Kolb WP; Esser AF; Müller-Eberhard HJ
J Immunol; 1979 Sep; 123(3):1071-7. PubMed ID: 381516
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of the seventh component of complement in rainbow trout.
Zarkadis IK; Duraj S; Chondrou M
Dev Comp Immunol; 2005; 29(2):95-102. PubMed ID: 15450749
[TBL] [Abstract][Full Text] [Related]
9. The SC5b-7 complex: formation, isolation, properties, and subunit composition.
Podack ER; Kolb WP; Müller-Eberhard HJ
J Immunol; 1977 Dec; 119(6):2024-9. PubMed ID: 410885
[TBL] [Abstract][Full Text] [Related]
10. Membrane attack complex of complement: a structural analysis of its assembly.
Podack ER; Esser AF; Biesecker G; Müller-Eberhard HJ
J Exp Med; 1980 Feb; 151(2):301-13. PubMed ID: 7356725
[TBL] [Abstract][Full Text] [Related]
11. Purification of the sixth and seventh component of human complement without loss of hemolytic activity.
Podack ER; Kolb WP; Müller-Eberhard HJ
J Immunol; 1976 Feb; 116(2):263-9. PubMed ID: 1249415
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
13. Complement component C7 is a plasminogen-binding protein.
Reinartz J; Hänsch GM; Kramer MD
J Immunol; 1995 Jan; 154(2):844-50. PubMed ID: 7814888
[TBL] [Abstract][Full Text] [Related]
14. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
Bhakdi S; Tranum-Jensen J; Klump O
J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
[TBL] [Abstract][Full Text] [Related]
15. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering.
Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O
J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292
[TBL] [Abstract][Full Text] [Related]
16. The structure of human complement component C7 and the C5b-7 complex.
DiScipio RG; Chakravarti DN; Muller-Eberhard HJ; Fey GH
J Biol Chem; 1988 Jan; 263(1):549-60. PubMed ID: 3335508
[TBL] [Abstract][Full Text] [Related]
17. Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer.
Bhakdi S; Tranum-Jensen J
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1818-22. PubMed ID: 6940190
[TBL] [Abstract][Full Text] [Related]
18. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
20. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
Dessauer A; Rother U; Rother K
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
